Search

Delia M. Ramirez

Examiner (ID: 4462)

Most Active Art Unit
1652
Art Unit(s)
1652
Total Applications
1518
Issued Applications
818
Pending Applications
200
Abandoned Applications
534

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17052553 [patent_doc_number] => 20210261987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => PRODUCTION OF ETHANOL WITH ONE OR MORE CO-PRODUCTS IN YEAST [patent_app_type] => utility [patent_app_number] => 17/182061 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182061 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182061
PRODUCTION OF ETHANOL WITH ONE OR MORE CO-PRODUCTS IN YEAST Feb 21, 2021 Abandoned
Array ( [id] => 17067617 [patent_doc_number] => 20210269832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => METHODS AND COMPOSITIONS FOR ENHANCED ETHANOL PRODUCTION [patent_app_type] => utility [patent_app_number] => 17/173412 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173412 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173412
METHODS AND COMPOSITIONS FOR ENHANCED ETHANOL PRODUCTION Feb 10, 2021 Abandoned
Array ( [id] => 18406071 [patent_doc_number] => 20230167422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => Parent Phytase Variant [patent_app_type] => utility [patent_app_number] => 17/997037 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997037
Parent Phytase Variant Feb 2, 2021 Pending
Array ( [id] => 18406071 [patent_doc_number] => 20230167422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => Parent Phytase Variant [patent_app_type] => utility [patent_app_number] => 17/997037 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997037
Parent Phytase Variant Feb 2, 2021 Pending
Array ( [id] => 18478087 [patent_doc_number] => 11691817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-04 [patent_title] => Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol [patent_app_type] => utility [patent_app_number] => 17/154190 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16225 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154190 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154190
Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol Jan 20, 2021 Issued
Array ( [id] => 17126501 [patent_doc_number] => 20210301269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY [patent_app_type] => utility [patent_app_number] => 17/154826 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154826 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154826
RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY Jan 20, 2021 Abandoned
Array ( [id] => 17126501 [patent_doc_number] => 20210301269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY [patent_app_type] => utility [patent_app_number] => 17/154826 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154826 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154826
RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY Jan 20, 2021 Abandoned
Array ( [id] => 17953662 [patent_doc_number] => 11479756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Ketoreductase polypeptides for the reduction of acetophenones [patent_app_type] => utility [patent_app_number] => 17/149463 [patent_app_country] => US [patent_app_date] => 2021-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 44198 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/149463
Ketoreductase polypeptides for the reduction of acetophenones Jan 13, 2021 Issued
Array ( [id] => 18223102 [patent_doc_number] => 20230062096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY [patent_app_type] => utility [patent_app_number] => 17/792101 [patent_app_country] => US [patent_app_date] => 2021-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792101 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/792101
COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY Jan 10, 2021 Pending
Array ( [id] => 18223102 [patent_doc_number] => 20230062096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY [patent_app_type] => utility [patent_app_number] => 17/792101 [patent_app_country] => US [patent_app_date] => 2021-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792101 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/792101
COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY Jan 10, 2021 Pending
Array ( [id] => 17258853 [patent_doc_number] => 20210371838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => NON-STANDARD AMINO ACID CONTAINING COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/144946 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144946 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/144946
Non-standard amino acid containing compositions and uses thereof Jan 7, 2021 Issued
Array ( [id] => 16848081 [patent_doc_number] => 20210148826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => Quantitative Flagellar Fluorescent Markers and Standards [patent_app_type] => utility [patent_app_number] => 17/142090 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142090 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/142090
Quantitative Flagellar Fluorescent Markers and Standards Jan 4, 2021 Abandoned
Array ( [id] => 17497782 [patent_doc_number] => 11286475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Tyrosol-producing recombinant [patent_app_type] => utility [patent_app_number] => 17/134633 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3754 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134633 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/134633
Tyrosol-producing recombinant Dec 27, 2020 Issued
Array ( [id] => 18739899 [patent_doc_number] => 20230348866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/786913 [patent_app_country] => US [patent_app_date] => 2020-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786913 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/786913
BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS Dec 23, 2020 Pending
Array ( [id] => 17968470 [patent_doc_number] => 11485987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Methods for inducing bioorthogonal reactivity [patent_app_type] => utility [patent_app_number] => 17/132532 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 25118 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132532 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/132532
Methods for inducing bioorthogonal reactivity Dec 22, 2020 Issued
Array ( [id] => 17274815 [patent_doc_number] => 20210381013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID [patent_app_type] => utility [patent_app_number] => 17/131930 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16407 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131930 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131930
ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID Dec 22, 2020 Pending
Array ( [id] => 16932762 [patent_doc_number] => 20210198651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => METHOD OF PURIFYING HIGH-PURITY UBIQUITIN [patent_app_type] => utility [patent_app_number] => 17/128550 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3167 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128550 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/128550
Method of purifying native ubiquitin Dec 20, 2020 Issued
Array ( [id] => 18229719 [patent_doc_number] => 20230068713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => HOST CELLS AND THEIR USE FOR PRODUCING RIBITOL AND FURTHER MONOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/779561 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779561 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/779561
HOST CELLS AND THEIR USE FOR PRODUCING RIBITOL AND FURTHER MONOSACCHARIDES Dec 16, 2020 Pending
Array ( [id] => 17604294 [patent_doc_number] => 11332767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Nucleic acids and recombinant host cells expressing acetylserotonin O-methyltransferase (ASMT) variants and their use in producing melatonin [patent_app_type] => utility [patent_app_number] => 17/109715 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 12049 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109715
Nucleic acids and recombinant host cells expressing acetylserotonin O-methyltransferase (ASMT) variants and their use in producing melatonin Dec 1, 2020 Issued
Array ( [id] => 17860018 [patent_doc_number] => 11441165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-13 [patent_title] => Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N [patent_app_type] => utility [patent_app_number] => 17/109473 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 16091 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109473 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109473
Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N Dec 1, 2020 Issued
Menu